JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 30, 2004; DOI: 10.1124/jpet.104.076893


0022-3565/05/3123-1132-1137$20.00
JPET 312:1132-1137, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.076893v1
312/3/1132    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oda, M.
Right arrow Articles by Morimoto, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oda, M.
Right arrow Articles by Morimoto, M.

NEUROPHARMACOLOGY

Quantitative and Fiber-Selective Evaluation of Dose-Dependent Nerve Blockade by Intrathecal Lidocaine in Rats

Mayuko Oda, Norihito Kitagawa, Bang-Xiang Yang, Tadahide Totoki, and Masatoshi Morimoto

Center for Laboratory Animals (M.O., N.K., M.M.) and Department of Anesthesiology (B.-X.Y., T.T.), Saga Medical School, Nabeshima, Saga, Japan; and Department of Anesthesiology (N.K.), Tsuruta Hospital, Ushizu, Saga, Japan

We investigated whether cutaneous stimulus threshold (CST), as determined using a Neurometer, could be used for quantitative and differential nerve evaluation of reversible and irreversible nerve block following intrathecal lidocaine administration in rats. Rats with intrathecal catheters were randomly assigned to one of five groups (saline or 2, 5, 10, or 20% lidocaine). Prior to and 4 days after drug administration, CST was determined at 5, 250, and 2000 Hz. In the 2% lidocaine group, CST from end of lidocaine infusion to recovery from anesthesia was also monitored. Skin-clamp testing and gait observation were performed for comparison with CST findings. Behavioral examinations revealed persistent sensory or motor impairment lasting 4 days in groups receiving ≥5% lidocaine but not in the saline and 2% lidocaine groups. With 2% lidocaine, return to baseline CSTs at 5 and 250 Hz was delayed compared with thresholds at 2000 Hz. Although CSTs in the 5% group at 5 and 250 Hz increased significantly, thresholds at 2000 Hz did not differ from those in rats administered saline. CSTs with ≥10% lidocaine displayed no differences between frequencies. At each frequency, CSTs for rats with ≥5% lidocaine increased in a clearly concentration-dependent manner. These results suggest that CST testing enables evaluation of the different nerve functions for A{beta}, A{delta}, and C fibers in rats for lidocaine concentrations ≤5% and allows quantitative assessment of persistent neurological deficit induced by lidocaine in rats.


Received September 2, 2004; accepted November 23, 2004.

Address correspondence to: Dr. Mayuko Oda, Center for Laboratory Animals, Saga Medical School, Nabeshima, Saga, 849-8501, Japan. E-mail: mayuko{at}mail.anes.saga-med.ac.jp




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
Y. Hayashi, K. Takimoto, M. B. Chancellor, K. A. Erickson, V. L. Erickson, T. Kirimoto, K. Nakano, W. C. de Groat, and N. Yoshimura
Bladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 {alpha}-subunit in rats with cystitis
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1661 - R1670.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Shibata, K. Naruse, H. Kamiya, M. Kozakae, M. Kondo, Y. Yasuda, N. Nakamura, K. Ota, T. Tosaki, T. Matsuki, et al.
Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Improves Diabetic Polyneuropathy in Rats
Diabetes, November 1, 2008; 57(11): 3099 - 3107.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics.